☆ 4.5 Article

Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation

METABOLIC BRAIN DISEASE (2023)

Related references

Note: Only part of the references are listed.

Review Clinical Neurology

Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson's disease: mechanisms and therapeutic implications

Luca Soraci et al.

Summary: Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by motor and non-motor disturbances, which are thought to be caused by neuroinflammation, oxidative stress, and the presence of alpha-synuclein (alpha-syn) aggregates. Aging of the immune system and immune dysfunction may contribute to neuroinflammation leading to PD onset and progression, with abnormal alpha-syn aggregation activating the NLRP3 inflammasome within microglial cells through toll-like receptors (TLRs). This review focuses on the TLR/NLRP3/Cas-1 pathway in PD-related immune dysfunction and explores potential therapeutic options for counteracting neuroinflammation and immune dysfunction since the early stages of the disease.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Integrative & Complementary Medicine

Wuzi Yanzong Pill Plays A Neuroprotective Role in Parkinson's Disease Mice via Regulating Unfolded Protein Response Mediated by Endoplasmic Reticulum Stress

Li Yen-rong et al.

Summary: The study found that Wuzi Yanzong Pill has protective effects on Parkinson's disease model mice, possibly by regulating the unfolded protein response and inhibiting endoplasmic reticulum stress-mediated neuronal apoptosis pathway.

CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2023)

Add to Collection

Review Clinical Neurology

Parkinsonism and tremor syndromes

Steven Bellows et al.

Summary: Tremor is a common movement disorder that can occur alone or coexist with other neurological and movement disorders. It can be a symptom of Parkinson's disease, dystonia, ataxia, and other disorders. Essential tremor may not only be associated with Parkinson's disease but also with other neurological disorders, suggesting the existence of different subtypes. Besides Parkinson's disease, tremor can also be a prominent feature in other parkinsonian disorders and movement disorders.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson's disease via inhibiting p38MAPK/NF-κB signaling pathway

Meiyun Cai et al.

Summary: The study demonstrated that KAE exerts neuroprotective effects by inhibiting the p38MAPK/NF-κB signaling pathway, ameliorating the behavioral deficits of PD rats, inhibiting neuroinflammatory response, and improving neuronal apoptosis.

NEUROCHEMISTRY INTERNATIONAL (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Biomarker of Neuroinflammation in Parkinson's Disease

Tsai-Wei Liu et al.

Summary: This review summarizes the recent advances in the research on inflammatory biomarkers for Parkinson's disease (PD) detection, as well as monitoring disease progression and treatment response. Neuroinflammation plays a crucial role in the pathogenesis and pathological processes of PD, and various anti-inflammatory medications have demonstrated neuroprotective effects in in vivo or in vitro PD models.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Endocrinology & Metabolism

Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway

Wei Hang et al.

Summary: The protective effect of Wuzi Yanzong Pill (WYP) on dopaminergic neurons in Parkinson's disease may be mediated through the activation of the PI3K/Akt signaling pathway to inhibit apoptosis and increase the secretion of neurotrophic factors.

METABOLIC BRAIN DISEASE (2022)

Add to Collection

Article Plant Sciences

The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine

Peng Chen et al.

Summary: Chinese herbs and prescriptions can treat Parkinson's disease through multiple pharmacological mechanisms, including eliminating pathogenic factors and restoring visceral function.

PHYTOMEDICINE (2022)

Add to Collection

Review Neurosciences

Amyloid ?, Tau, and ?-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

Urmi Sengupta et al.

Summary: This review summarizes the histopathological features of specific protein aggregation in several neurodegenerative diseases and discusses their overlap. It also highlights the synergistic interplay among Aβ, tau, and alpha-Syn in these diseases, suggesting a protein triumvirate.

PROGRESS IN NEUROBIOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease

Jun Ho Lee et al.

Summary: Alzheimer's disease and Parkinson's disease, the most common neurodegenerative diseases, are associated with the release of NLRP3 inflammasome-mediated proinflammatory cytokines by the excessive activation of microglia. Although studies suggest that the NLRP3 inflammasome plays an important role in disease development, its exact function and regulation are still unclear. Studies on natural products show promise as a potential strategy for treating these diseases by regulating NLRP3 inflammasome assembly.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Pharmacology & Pharmacy

Neurodegenerative Disease and the NLRP3 Inflammasome

Jonathan A. Holbrook et al.

Summary: The prevalence of neurodegenerative diseases is increasing, characterized by progressive neuronal loss, protein aggregation, metabolic abnormalities, and immune dysregulation. Research has shown that low-grade systemic inflammation may impact the development and progression of these diseases, and inflammation may also be a causative factor.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Immunology

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease

Yunna Li et al.

Summary: Recent studies have shown that the excessive activation of microglia and release of pro-inflammatory cytokines play crucial roles in the pathogenesis and progression of Parkinson's disease (PD). The elevated level of NLRP3 inflammasome in activated microglia in the substantia nigra of PD patients exacerbates the pathology and accelerates disease progression. Current therapeutic drugs for PD primarily focus on relieving clinical symptoms, as there are no established strategies to stop or reverse the disease.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Cell Biology

The Positive Role and Mechanism of Herbal Medicine in Parkinson's Disease

Rong Yin et al.

Summary: Parkinson's disease is a complex neurodegenerative disease caused by the progressive impairment of midbrain nigral dopaminergic neurons. The underlying pathogenesis of PD remains unclear, making the development of disease-modifying drugs challenging. Herbal medicines, particularly from China and India, have gained attention due to their potential curative effects on PD.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Add to Collection

Article Geriatrics & Gerontology

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology

David K. Simon et al.

CLINICS IN GERIATRIC MEDICINE (2020)

Add to Collection

Review Clinical Neurology

Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease

Md Ezazul Haque et al.

MOVEMENT DISORDERS (2020)

Add to Collection

Article Neurosciences

Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation

Lei Yang et al.

NEUROBIOLOGY OF DISEASE (2020)

Add to Collection

Article Cell Biology

Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis

Xue Zhang et al.

AGING-US (2020)

Add to Collection

Article Clinical Neurology

Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/Caspase-1/GSDMD Pathway in MPTP-Induced Mice Model of Parkinson's Disease

Wenjuan Rui et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)

Add to Collection

Review Cell Biology

Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications

Marta Pajares et al.

CELLS (2020)

Add to Collection

Review Neurosciences

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Hyuk Sung Kwon et al.

TRANSLATIONAL NEURODEGENERATION (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease

Chrysoula Marogianni et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Immunology

TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in vivo model

Michela Campolo et al.

BRAIN BEHAVIOR AND IMMUNITY (2019)

Add to Collection

Article Immunology

Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study

Koustav Chatterjee et al.

JOURNAL OF NEUROIMMUNOLOGY (2019)

Add to Collection

Review Neurosciences

The Emerging Evidence of the Parkinson Pandemic

E. Ray Dorsey et al.

JOURNAL OF PARKINSONS DISEASE (2018)

Add to Collection

Article Integrative & Complementary Medicine

Antineuroinflammatory Effects of Modified Wu-Zi-Yan-Zong Prescription in β-Amyloid-Stimulated BV2 Microglia via the NF-κB and ERK/p38 MAPK Signaling Pathways

Qian Yu et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease

Adelin Gustot et al.

BIOCHEMICAL JOURNAL (2015)

Add to Collection

Article Multidisciplinary Sciences

Cryopyrin activates the inflammasome in response to toxins and ATP

S Mariathasan et al.

NATURE (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.